Rituximab, an anti-CD20 monoclonal antibody, is generally a safe and well-tolerated drug. Severe acute thrombocytopenia following administration of rituximab is a rare phenomenon, with few previously reported cases in the literature. We report a case of an 84-year old male with a diagnosis of mantle cell lymphoma who suffered severe acute thrombocytopenia following rituximab infusion. A literature review of the previously published cases is also presented.
机构:
Metropolitan Hosp Ctr, Dept Internal Med, New York Med Coll, New York, NY 10029 USAMetropolitan Hosp Ctr, Dept Internal Med, New York Med Coll, New York, NY 10029 USA
机构:
Metropolitan Hosp Ctr, Dept Internal Med, New York Med Coll, New York, NY 10029 USAMetropolitan Hosp Ctr, Dept Internal Med, New York Med Coll, New York, NY 10029 USA